Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with long COVID and those who experienced side effects from mRNA vaccines are seeking Novavax’s protein-based offering.
Many nursing homes will not begin inoculations until well into October or even November.
The protein-based vaccine works in a different way than the mRNA vaccines from Moderna and Pfizer-BioNTech.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.
The protein subunit vaccine provides 100% protection against moderate or severe disease, hospitalization and death.
The protein vaccine was 96% effective against the original SARS-CoV-2 coronavirus, but less so against new variants.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.